Tuberculosis history |
96 per 1000 |
239 per 1000 (158 to 360) |
RR 2.49 (1.65 to 3.75) |
1400 (6) |
⊕○○○ |
|
Smoking history |
635 per 1000 |
794 per 1000 (730 to 857) |
RR 1.25 (1.15 to 1.35) |
1267 (5) |
⊕⊕○○ |
|
Pseudomonas aeruginosa infection |
28 per 1000 |
122 per 1000 (85 to 176) |
RR 4.36 (3.04 to 6.27) |
1479 (7) |
⊕○○○ |
|
Purulent sputum |
70 per 1000 |
216 per 1000 (117 to 398) |
RR 3.09 (1.68 to 5.69) |
514 (4) |
⊕○○○ |
|
Purulent mucus sputum |
122 per 1000 |
510 per 1000 (314 to 828) |
RR 4.18 (2.57 to 6.79) |
269 (2) |
⊕○○○ |
|
Positive sputum culture |
284 per 1000 |
443 per 1000 (315 to 616) |
RR 1.56 (1.11 to 2.17) |
269 (2) |
⊕○○○ |
|
Admission within the past year |
222 per 1000 |
404 per 1000 (335 to 488) |
RR 1.82 (1.51 to 2.20) |
402 (3) |
⊕○○○ |
|
Daily dyspnea |
294 per 1000 |
706 per 1000 (562 to 885) |
RR 2.40 (1.91 to 3.01) |
269 (2) |
⊕○○○ |
|
Hypertension history |
362 per 1000 |
398 per 1000 (315 to 500) |
RR 1.10 (0.87 to 1.38) |
505 (2) |
⊕○○○ |
|
Diabetes history |
208 per 1000 |
275 per 1000 (191 to 395) |
RR 1.32 (0.92 to 1.90) |
505 (2) |
⊕○○○ |
|
Female |
328 per 1000 |
358 per 1000 (298 to 430) |
RR 1.09 (0.91 to 1.31) |
1669 (8) |
⊕○○○ |
|
Mucous sputum |
546 per 1000 |
158 per 1000 (27 to 906) |
RR 0.29 (0.05 to 1.66) |
361 (3) |
⊕○○○ |
|
Klebsiella pneumoniae infection |
49 per 1000 |
45 per 1000 (32 to 64) |
RR 0.92 (0.66 to 1.30) |
1387 (6) |
⊕○○○ |
|
Escherichia coli infection |
21 per 1000 |
40 per 1000 (20 to 79) |
RR 1.92 (0.99 to 3.75) |
1185 (4) |
⊕○○○ |
|
Streptococcus pneumoniae infection |
10 per 1000 |
8 per 1000 (4 to 21) |
RR 0.84 (0.35 to 2.05) |
1101 (4) |
⊕○○○ |
|
Acinetobacter baumannii infection |
41 per 1000 |
32 per 1000 (16 to 64) |
RR 0.79 (0.40 to 1.55) |
965 (3) |
⊕○○○ |
|
Stenotrophomonas maltophilia infection |
30 per 1000 |
7 per 1000 (1 to 56) |
RR 0.23 (0.03 to 1.86) |
333 (2) |
⊕○○○ |
|
Enterobacter cloacae infection |
18 per 1000 |
24 per 1000 (9 to 62) |
RR 1.33 (0.52 to 3.42) |
832 (2) |
⊕○○○ |
|
Haemophilus infection |
69 per 1000 |
98 per 1000 (35 to 275) |
RR 1.42 (0.50 to 3.98) |
202 (2) |
⊕○○○ |
|
Anticholinergic therapy |
713 per 1000 |
791 per 1000 (684 to 913) |
RR 1.11 (0.96 to 1.28) |
282 (2) |
⊕○○○ |
|
FEV1/FVC |
The mean FEV1/FVC in the control group was 0 |
The mean FEV1/FVC in the trial group was 0.61 standard deviations lower (0.89 lower to 0.32 lower) |
- |
1326 (6) |
⊕○○○ |
|
FEV1% |
The mean FEV1% in the control group was 0 |
The mean FEV1% in the trial group was 0.96 standard deviations lower (1.22 lower to 0.71 lower) |
- |
269 (2) |
⊕○○○ |
|
FEV1%pred |
The mean FEV1%pred in the control group was 0 |
The mean FEV1%pred in the trial group was 0.38 standard deviations lower (0.50 lower to 0.26 lower) |
- |
1155 (4) |
⊕⊕○○ |
|
PaO2
|
The mean PaO2 in the control group was 0 |
The mean PaO2 in the trial group was 0.14 standard deviations lower (0.27 lower to 0.01 lower) |
- |
985 (3) |
⊕⊕○○ |
|
Hospital stay |
The mean hospital stay in the control group was 0 |
The mean hospital stay in the trial group was 0.41 standard deviations higher (0.26 lower to 0.56 higher) |
- |
766 (3) |
⊕⊕○○ |
|
Duration of symptoms |
The mean duration of symptoms in the control group was 0 |
The mean duration of symptoms in the trial group was 0.31 standard deviations higher (0.05 lower to 0.57 higher) |
- |
245 (2) |
⊕○○○ |
|
CRP |
The mean CRP in the control group was 0 |
The mean CRP in the trial group was 0.50 standard deviations higher (0.07 lower to 0.93 higher) |
- |
956 (4) |
⊕○○○ |
|
WBC |
The mean WBC in the control group was 0 |
The mean WBC in the trial group was 0.72 standard deviations higher (0.07 lower to 1.36 higher) |
- |
1118 (4) |
⊕○○○ |
|
N% |
The mean N% in the control group was 0 |
The mean N% in the trial group was 0.91 standard deviations higher (0.09 lower to 1.72 higher) |
- |
1932 (3) |
⊕○○○ |
|
Smoking index (pack/year) |
The mean smoking index in the control group was 0 |
The mean smoking index in the trial group was 0.72 standard deviations higher (0.07 lower to 1.50 higher) |
- |
684 (5) |
⊕○○○ |
|
BMI |
The mean BMI in the control group was 0 |
The mean BMI in the trial group was 0.13 standard deviations lower (0.37 lower to 0.11 higher) |
- |
1022 (3) |
⊕○○○ |
|
Age |
The mean age in the control group was 0 |
The mean age in the trial group was 0.15 standard deviations higher (0.10 lower to 0.39 higher) |
- |
1669 (8) |
⊕○○○ |
|
PaCO2
|
The mean PaCO2 in the control group was 0 |
The mean PaCO2 in the trial group was 0.31 standard deviations higher (0.01 lower to 0.64 higher) |
- |
985 (3) |
⊕○○○ |
|
ESR |
The mean ESR in the control group was 0 |
The mean ESR in the trial group was 0.53 standard deviations higher (0.65 lower to 1.72 higher) |
- |
985 (3) |
⊕○○○ |
|
Hb |
The mean Hb in the control group was 0 |
The mean Hb in the trial group was 0.12 standard deviations lower (0.25 lower to 0.00 higher) |
- |
985 (3) |
⊕⊕○○ |
|
FIB |
The mean FIB in the control group was 0 |
The mean FIB in the trial group was 0.78 standard deviations higher (0.01 lower to 1.58 higher) |
- |
1155 (4) |
⊕○○○ |
|
Albumin |
The mean albumin in the control group was 0 |
The mean albumin in the trial group was 0.05 standard deviations lower (0.27 lower to 0.18 higher) |
- |
323 (2) |
⊕○○○ |
|